MedTrace Logo

Ectoin® Mouth Wash for the Prevention and Treatment of Chemotherapy-induced Oral Mucositis

NCT02816515 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2018-01-18

No results posted yet for this study

Summary

This is a 3-week, non-interventional, observational study of patients undergoing chemotherapy (sutent) designed as a three-arm parallel study. In this study, the efficacy of Ectoin containing mouthwash given prophylactically for the prevention of mucositis in patients before radio- and/or chemotherapy; as well as during radio- and/or chemotherapy for patients with mucositis compared to standard treatment should be investigated. The study doesn't intervene with routine treatment strategy.

Conditions

Sponsors & Collaborators

  • Bitop AG

    lead INDUSTRY

Principal Investigators

  • Lajos Géczi, PhD · National Institute of TB and Pulmonology

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-10-24
Completion
2017-10-24

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816515 on ClinicalTrials.gov